Aerobic Exercise in Early Subacute Stroke
Not Applicable
Completed
- Conditions
- Stroke
- Registration Number
- NCT02107768
- Lead Sponsor
- Klas Sandberg
- Brief Summary
The purpose of this study was to investigate the effects of early intensive aerobic exercise regarding aerobic capacity, gait and balance, Health Related Quality of Life and participation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 56
Inclusion Criteria
- Ability to understand Swedish language.
- Ability to walk 5 meters with or without the support of any means or person.
- Be able to get up on a cycle ergometer and cycle in their own chosen pace.
- Approval of medically responsible physician to conduct physical training in groups.
Exclusion Criteria
- Medical or neurological diseases that may affect the exercise execution.
- Patients for whom transportation to and from hospital can not be arranged during intervention period
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Aerobic capacity Baseline,3month cardiorespiratory stress test (Watt)
- Secondary Outcome Measures
Name Time Method Walking capacity Baseline,3month Six minute walk test (6MWT ), 10 meters Walking test
Balance Baseline,3month Time Up and Go(TUG) ,Single Leg Stance(SLS)
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie aerobic exercise-induced neuroplasticity post-stroke?
How does early intense aerobic exercise compare to standard rehabilitation in subacute stroke recovery?
Which biomarkers predict response to aerobic exercise in early subacute stroke patients?
What adverse events are associated with early high-intensity aerobic exercise post-stroke?
Are there synergistic effects of combining aerobic exercise with neuroprotective agents in stroke rehabilitation?